Search research articles
Contact Us
Filters
Showing results (101-110 of 110) with videos related to
Page
of 11
Sort By:
You have reached the last page of results.
This site can display upto 110 results.
Journal of Medicinal Chemistry
|
October 10, 2008
Potent, selective and orally bioavailable dihydropyrimidine inhibitors of Rho kinase (ROCK1) as potential therapeutic agents for cardiovascular diseases
Clark A Sehon, Gren Z Wang, Andrew Q Viet, et al.
Journal of Medicinal Chemistry
|
April 18, 2003
Indole naphthyridinones as inhibitors of bacterial enoyl-ACP reductases FabI and FabK
Mark A Seefeld, William H Miller, Kenneth A Newlander, et al.
Microbiology Spectrum
|
April 17, 2023
Development of a Broth Microdilution Method To Characterize Chlorhexidine MICs among Bacteria Collected from 2005 to 2019 at Three U.S. Sites
Joseph D Lutgring, Julian E Grass, David Lonsway, et al.
Microbial Drug Resistance (Larchmont, N.Y.)
|
February 16, 2022
Molecular Characterization of Carbapenem-Resistant Enterobacterales Collected in the United States
Maria Karlsson, Joseph D Lutgring, Uzma Ansari, et al.
Infection Control and Hospital Epidemiology
|
February 14, 2022
Epidemiology of extended-spectrum β-lactamase-producing Enterobacterales in five US sites participating in the Emerging Infections Program, 2017
Nadezhda Duffy, Maria Karlsson, Hannah E Reses, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
Discovery of GSK2126458, a Highly Potent Inhibitor of PI3K and the Mammalian Target of Rapamycin
Steven D Knight, Nicholas D Adams, Joelle L Burgess, et al.
Plos One
|
April 15, 2021
Demographic, clinical, and epidemiologic characteristics of persons under investigation for Coronavirus Disease 2019-United States, January 17-February 29, 2020
Olivia L McGovern, Mark Stenger, Sara E Oliver, et al.
Bioorganic & Medicinal Chemistry
|
October 15, 2020
The exploration of aza-quinolines as hematopoietic prostaglandin D synthase (H-PGDS) inhibitors with low brain exposure
Rodolfo Cadilla, David N Deaton, Young Do, et al.
Journal of Medicinal Chemistry
|
January 5, 2007
Discovery of aminofurazan-azabenzimidazoles as inhibitors of Rho-kinase with high kinase selectivity and antihypertensive activity
Robert A Stavenger, Haifeng Cui, Sarah E Dowdell, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 14, 2020
Coronavirus Disease 2019 (COVID-19) in Americans Aboard the Diamond Princess Cruise Ship
Mateusz M Plucinski, Megan Wallace, Anna Uehara, et al.
Page
of 11
Search research articles
Search
Showing results (101-110 of 110) with videos related to
Sort By:
Page
of 11
You have reached the last page of results.
This site can display upto 110 results.
Journal of Medicinal Chemistry
|
October 10, 2008
Potent, selective and orally bioavailable dihydropyrimidine inhibitors of Rho kinase (ROCK1) as potential therapeutic agents for cardiovascular diseases
Clark A Sehon, Gren Z Wang, Andrew Q Viet, et al.
Journal of Medicinal Chemistry
|
April 18, 2003
Indole naphthyridinones as inhibitors of bacterial enoyl-ACP reductases FabI and FabK
Mark A Seefeld, William H Miller, Kenneth A Newlander, et al.
Microbiology Spectrum
|
April 17, 2023
Development of a Broth Microdilution Method To Characterize Chlorhexidine MICs among Bacteria Collected from 2005 to 2019 at Three U.S. Sites
Joseph D Lutgring, Julian E Grass, David Lonsway, et al.
Microbial Drug Resistance (Larchmont, N.Y.)
|
February 16, 2022
Molecular Characterization of Carbapenem-Resistant Enterobacterales Collected in the United States
Maria Karlsson, Joseph D Lutgring, Uzma Ansari, et al.
Infection Control and Hospital Epidemiology
|
February 14, 2022
Epidemiology of extended-spectrum β-lactamase-producing Enterobacterales in five US sites participating in the Emerging Infections Program, 2017
Nadezhda Duffy, Maria Karlsson, Hannah E Reses, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
Discovery of GSK2126458, a Highly Potent Inhibitor of PI3K and the Mammalian Target of Rapamycin
Steven D Knight, Nicholas D Adams, Joelle L Burgess, et al.
Plos One
|
April 15, 2021
Demographic, clinical, and epidemiologic characteristics of persons under investigation for Coronavirus Disease 2019-United States, January 17-February 29, 2020
Olivia L McGovern, Mark Stenger, Sara E Oliver, et al.
Bioorganic & Medicinal Chemistry
|
October 15, 2020
The exploration of aza-quinolines as hematopoietic prostaglandin D synthase (H-PGDS) inhibitors with low brain exposure
Rodolfo Cadilla, David N Deaton, Young Do, et al.
Journal of Medicinal Chemistry
|
January 5, 2007
Discovery of aminofurazan-azabenzimidazoles as inhibitors of Rho-kinase with high kinase selectivity and antihypertensive activity
Robert A Stavenger, Haifeng Cui, Sarah E Dowdell, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 14, 2020
Coronavirus Disease 2019 (COVID-19) in Americans Aboard the Diamond Princess Cruise Ship
Mateusz M Plucinski, Megan Wallace, Anna Uehara, et al.
Page
of 11